Cannabis extract shows promise for Hard-to-Treat seizures in rare disease
NCT ID NCT07403266
First seen Feb 11, 2026 · Last updated May 09, 2026 · Updated 8 times
Summary
This study tests a full-spectrum cannabis extract (YCJ-01) to see if it can reduce seizures in people with tuberous sclerosis complex (TSC) whose epilepsy does not respond to standard treatments. About 84 participants aged 2 to 65 will receive either the extract or a placebo. The main goal is to measure changes in monthly seizure counts and check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBEROUS SCLEROSIS COMPLEX (TSC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Ruber Internacional
RECRUITINGMadrid, 28034, Spain
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.